CeloNova BioSciences Inc.'s CATANIA Coronary Stent System features a NanoThin Polyzene-F surface treatment.

The CATANIA Coronary Stent System carries a CE Mark and is currently available for sale outside the U.S.

October 5, 2008 - New research shows warfarin therapy is significantly underused in patients being treated for atrial fibrillation (AF) in the U.S.

The new study is published in the October edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society. It concludes that not only is warfarin not prescribed as often as it could be, in many cases when warfarin is administered, it is not used at optimal therapeutic levels.

October 6, 2008 - Physio-Control Inc. last week announced FDA clearance to market the LIFEPAK 20e defibrillator/monitor in the U.S.

EmpowerCTA injector system offers both ACIST’s patented extravasation detection accessory (EDA) and a saline chase. This CT injector features air embolism protection, on-the-fly flow rate manipulation and syringe loading and arming at the injector.

EmpowerMR injector system has multiple features created to cope with the problem of electrical interference in the magnetic field of the MR scanner, including a hydraulic control system instead of the shielded electrical control components used by most other MR injector systems.

Automated workflow enhancements and clinical applications for the Aquilion CT line are designed to reduce patient radiation dose, provide faster diagnosis and maximize patient comfort.

This case is a routine coronary CTA with the focus on the coronary arteries. The patient was a middle-aged male with a family history of coronary artery disease, moderate risk profile and atypical chest pain. The EKG did not indicate myocardial ischemia and there was no enzyme leak.

October 3, 2008 - A Swedish study shows patients transported with ambulance due to ST-elevation myocardial infarction (STEMI), there was a significant association between early recognition and treatment followed by fast tracking to a coronary care unit (CCU) and long-term survival.

October 3, 2008 - Sadra Medical today said the enrollment and treatment of four new patients in the second phase of its European Feasibility Study of the Sadra Lotus Aortic Heart Valve System.

The system is designed to enable physicians to replace a diseased aortic valve utilizing a less invasive approach, navigating the valve through the patient’s arteries using a catheter-based delivery system and thereby eliminating the need for an open chest surgical procedure.

October 2, 2008 - ZOLL Medical Corp. said today the Kuopio University Hospital (KUH), one of the largest hospitals in Finland, successfully implemented the AutoPulse Non-invasive Cardiac Support Pump in its intensive care department.

KUH is the first hospital in Finland to establish protocols for using the AutoPulse. Jouni O. Kurola, M.D., department of anesthesiology and intensive care, KUH, recommended the implementation following a successful evaluation of an AutoPulse provided to the hospital by ZOLL.

October 2, 2008 - Wireless medical technology company CardioNet Inc. today released its new atrial fibrillation (AF) reporting package to enhance its current AF management program.

The CardioNet AF Management Program offers a comprehensive tool to the physician for the diagnosis, treatment and management of their AF patients. The program provides physicians with a flexible monitoring program to evaluate the clinical efficacy of catheter and surgical ablation procedures allowing improved management of these post surgical patients.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now